Related by context. All words. (Click for frequent words.) 67 Molecular Targets 63 AACR NCI EORTC 60 Biological Therapy 60 Cancer Therapies 60 Protein Therapeutics 60 Molecular Diagnostics 59 Drug Discovery 59 Elixir Pharmaceuticals 58 Merrimack Pharmaceuticals 58 Biomarker 58 targeting CD# 58 TransMolecular 58 Avila Therapeutics 58 Cancer Immunotherapy 58 Cambridge Healthtech Institute 58 Biotherapeutics 58 Hybridon 57 KineMed 57 Molecular Medicine Tri 57 Regado Biosciences 57 ASH Annual Meeting 57 Agios Pharmaceuticals 57 Antibody Therapeutics 57 Tissue Engineering 57 Ascenta Therapeutics 57 EORTC NCI AACR 57 Cellzome 57 Preclinical Development 56 Sangamo BioSciences 56 cancer therapeutics 56 immunotherapeutics 56 Gynecologic Cancer Society 56 InNexus Biotechnology 56 Antisense 56 Infinity Pharmaceuticals 56 Epizyme 56 Chemokine 56 Targeted Therapies 56 Medicinal Chemistry 56 RNA Interference 56 Nanobiotechnology 56 Mirna Therapeutics 56 IL# PE#QQR 56 entinostat 56 Small Molecule 56 Opportunistic Infections 55 Novel Therapeutics 55 FoldRx Pharmaceuticals Inc. 55 Neurodegenerative Diseases 55 Tranzyme Pharma 55 Cancers Symposium 55 Archemix Corp. 55 Memgen 55 Cancer Therapeutic 55 AACR Meeting 55 Autoimmunity 55 novel peptide 55 Martinsried Germany 55 Callisto Pharmaceuticals Inc. 55 Cancer Vaccines 55 Gemin X 55 Biotherapeutic 55 Epiphany Biosciences 55 Preclinical 55 Gene Therapy ASGT 55 Kinase Inhibitors 55 Antiviral Research 55 Ocera Therapeutics 55 Taligen Therapeutics 55 Aptamer 55 Molecular Imaging 55 Idera Pharmaceuticals 55 Monoclonal Antibodies 55 ChemoCentryx 55 Retroviruses 55 Metabolic Disease 55 BioMedical Research 55 Prolexys 55 Immunotherapy 55 Hsp# Inhibitor 55 Chemotherapy ICAAC 55 Cell Signalling 55 FluoroPharma 55 selective kinase inhibitor 55 Hydra Biosciences 55 NanoBio Corporation 54 Aileron Therapeutics 54 Cell Therapy 54 Tumor Biology 54 Hana Biosciences 54 DARA BioSciences 54 OncoMed Pharmaceuticals 54 immunotherapies 54 CoMentis 54 Affimed Therapeutics AG 54 #nd EORTC NCI 54 RNAi Therapeutics 54 JAK1 54 Cancer Therapy 54 Kinase Inhibitor 54 Cardiovascular Therapeutics 54 Biodesix 54 Clinical Research 54 FibroGen 54 RxKinetix 54 Preclinical Data 54 OncoMed 54 Receptos 54 OvaRex R 54 Antigen Express 54 Plexxikon 54 Sphingomab 54 Portola Pharmaceuticals 54 Corixa Corporation 54 depsipeptide 54 Nasdaq HALO 54 Quark Pharmaceuticals 54 Opportunistic Infections CROI 54 Stemgent 54 Protein Polymer Technologies 54 Immunotope 54 Immunotherapeutic 54 Chroma Therapeutics 54 Annual BIO 54 Sirion Therapeutics 54 AACR #st Annual Meeting 54 CROI 54 Targeted Anticancer Therapies 54 Drug Repositioning 54 antiviral compounds 54 EnVivo Pharmaceuticals 54 Aegis Therapeutics 54 Cempra Pharmaceuticals 54 Nasdaq HALO biopharmaceutical 54 Regulus Therapeutics 54 Cancer Biology 54 Ichor Medical Systems 54 Presents Preclinical Data 54 Neurodegenerative Disease 54 Cara Therapeutics 54 Astex Therapeutics 54 Presidio Pharmaceuticals 54 Lpath 54 Liver Diseases 54 Anchor Therapeutics 53 novel peptides 53 Gastrointestinal Cancers Symposium 53 Catalyst Biosciences 53 Biogen Idec NASDAQ BIIB 53 BIOCOM Investor Conference 53 Hepatitis C Virus 53 Clinical Trial Results 53 KRN# 53 Therapeutics Roundtable 53 aTyr Pharma 53 Ardea Biosciences 53 Metabolomics 53 EORTC NCI 53 Breast Cancer Symposium 53 Biopharmaceutical Manufacturing 53 Cancer iSBTc 53 Molecular Biometrics 53 Acuity Pharmaceuticals 53 Neuropathic Pain 53 AACR symposium 53 Trellis Bioscience 53 Pharmaceutics 53 AACR NCI EORTC Molecular 53 BN ImmunoTherapeutics 53 Systemic Delivery 53 Athenagen 53 Oxford Genome Sciences 53 RegeneRx Biopharmaceuticals 53 Pepscan Therapeutics 53 ImmunoCellular Therapeutics 53 TolerRx 53 Vaccinex 53 Omacetaxine 53 Completes Patient Enrolment 53 G Protein Coupled 53 Ceragenix 53 DermTech 53 Biomanufacturing 53 Medtech Insight Investment 53 Phylogica 53 Melior Discovery 53 Aduro BioTech 53 Gastrointestinal Cancer 53 Romidepsin 53 ICAAC 53 Biomarkers 53 Present Preclinical Data 53 GammaCan 53 Amira Pharmaceuticals 53 NASDAQ ARIA 53 Æterna Zentaris 53 Stem Cell Research ISSCR 53 Preclinical Studies 53 Ambrx 53 IRX Therapeutics 53 Charlesson 53 Cellular Therapy 53 Nasdaq RXII 53 Peptides 53 Biopharmaceuticals 53 NanoTherapies 53 stem cell therapeutics 53 Pluristem Therapeutics 53 ASCO Annual Meeting 53 Tranzyme 53 Alder Biopharmaceuticals 53 BiPar 53 Response Genetics 53 Surface Logix 53 Ceregene 53 BIO InvestorForum 53 Genetix Pharmaceuticals 53 ImmunoGen Inc. 53 RNA Therapeutics 53 Monoclonal Antibody 53 Seaside Therapeutics 53 Therapeutic Targets 53 st Annual Meeting 53 Array BioPharma 53 OTCBB PYTO FWB ET6 53 pralatrexate injection folate analogue 53 Knopp Neurosciences 53 Semafore 53 GlobeImmune 52 Cequent Pharmaceuticals 52 TrovaGene 52 vascular disrupting agent 52 Metaphore 52 Predictive Biosciences 52 Outcome Sciences 52 AACR Annual Meeting 52 Combination REOLYSIN R 52 Malignant Lymphoma 52 Nasdaq CBST 52 AIDS Vaccine 52 Helicon Therapeutics 52 Apthera 52 KAI Pharmaceuticals 52 CoDa Therapeutics 52 Accentia Biopharmaceuticals 52 Personalized Medicine 52 Akebia Therapeutics 52 VisEn Medical 52 Clinical Trials 52 Protein Kinases 52 Clinical Oncology ASCO Annual 52 MEK inhibitors 52 Elesclomol 52 AAGP 52 Interventional Oncology 52 Fate Therapeutics 52 Anti Tumor 52 NKT Therapeutics 52 Ocular Diseases 52 GlycoMimetics 52 Biopharmaceutical 52 Neuro Oncology 52 Oligonucleotides 52 Neck Cancer 52 Apitope 52 Source MDx 52 Antiangiogenic 52 therapeutics 52 Singulex 52 Experimental Therapeutics 52 Biodefense Vaccines 52 GeneThera Inc. 52 Immunotherapeutics 52 Therapeutics TCT scientific 52 Coley Pharmaceutical Group 52 Personalized Immunotherapy 52 Oncologic 52 JMP Securities Healthcare 52 DermTech International 52 Antibody Discovery 52 Gemin X Pharmaceuticals 52 Peptide 52 Synergy Pharmaceuticals 52 Avecia Biotechnology 52 rxRNA 52 Clinical Data 52 Ophthotech 52 Nereus Pharmaceuticals 52 Preclinical Study 52 FoldRx 52 Cancer Stem Cells 52 ICAAC IDSA 52 Molecular Pharmacology 52 A3 adenosine receptor 52 AMEX RGN 52 NovaBay Pharmaceuticals 52 Taligen 52 Antimicrobial Agents 52 anticancer therapeutics 52 Pertuzumab 52 ENESTnd 52 Tetraphase Pharmaceuticals 52 AACR 52 VentiRx 52 Ambit Biosciences 52 Experimental Medicine 52 Immunobiology 52 AASLD 52 cancer immunotherapies 52 SCIB1 52 Chronix 52 Vascular Targeting Agents 52 ESMO 52 Liver EASL 52 Phase Ib II 52 Onconova 52 Alnylam Nasdaq ALNY 52 Senexis 52 OncoMethylome Sciences 52 Novel Therapeutic 52 Clinical Oncology Annual Meeting 52 Akesis Pharmaceuticals 52 Ercole Biotech 52 Idenix Pharmaceuticals 52 Devax 52 Molecular Profiling 52 Micromet 52 mitogen activated ERK kinase 52 Tolerx 52 ASGT 52 ARVO 52 monoclonal antibodies 52 Noscira 52 Amorcyte 52 Aegera 52 RGB # 52 Cylene Pharmaceuticals 52 San Antonio Breast Cancer 52 Nasdaq ENZN 52 Windhover Therapeutic Area 52 developer Antisoma plc 52 Reports Preclinical Data 52 Quintessence Biosciences 52 Veridex LLC 52 Pervasis 52 Biosciences 52 histone deacetylase HDAC inhibitor 52 Cellectar 52 Drug Delivery 52 FOLOTYN ® 52 NeurAxon Inc. 52 Inc. Nasdaq IMGN 52 pan HDAC inhibitor 51 Nautilus Biotech 51 LSE ASM 51 preclinical 51 ASCO GI 51 Versartis 51 Angiogenesis 51 Dendritic Cells 51 Addrenex Pharmaceuticals 51 Afferent Pharmaceuticals 51 Regado 51 Anticalin R 51 Therion Biologics 51 Javelin Pharmaceuticals AMEX JAV 51 MacroMed 51 HistoRx 51 VitiGam 51 ChemGenex Pharmaceuticals 51 Proteomics 51 Clinical Oncology Gastrointestinal Cancers 51 EORTC NCI AACR Symposium 51 Therapeutics TCT 51 Antiviral 51 BioProcess International 51 Locked Nucleic Acid 51 Myriad Pharmaceuticals Inc. 51 Synta Pharmaceuticals 51 ImQuest Pharmaceuticals 51 Synosia Therapeutics 51 Mesoblast Limited ASX MSB 51 Neurodegenerative Disorders 51 Therapeutic Antibody 51 Silodosin 51 IAP inhibitors 51 Exploit collaboration 51 ActivBiotics 51 Tissue Repair 51 BioSystems 51 Neuroscience 51 #th Annual Interscience 51 Jennerex 51 Therapeutic Competitors Companies 51 Ocular Pharmacology 51 Xanthus Pharmaceuticals Inc. 51 Tarvacin TM 51 Flow Cytometry 51 Fresenius Biotech 51 AltheaDx 51 AngioChem 51 Bortezomib 51 Wellstat 51 cancer immunotherapy 51 Biotechnology 51 ARRY # 51 Bioscience 51 HepaLife Technologies Inc. 51 Poster Presentation 51 Adnexus Therapeutics 51 Oligonucleotide 51 MitoSciences 51 Tarvacin 51 NASDAQ PCYC 51 TheraGenetics 51 NovaBay Aganocide compounds 51 Ascent Therapeutics 51 NASDAQ ARRY 51 Vegenics 51 Circ Pharma 51 p# inhibitor 51 Gastrointestinal Oncology 51 Holmes Biopharma 51 Enanta Pharmaceuticals 51 Hematology Annual Meeting 51 nicotinic alpha 7 51 Nuon Therapeutics 51 Oxis International 51 Intellikine 51 Carfilzomib 51 Sapacitabine 51 Specialty Pharma 51 Semafore Pharmaceuticals 51 oncology therapeutics 51 Angioblast 51 Oxford BioMedica 51 Myrexis Inc. 51 Oncology 51 TetraLogic Pharmaceuticals 51 Sorrento Therapeutics 51 Liver Diseases AASLD 51 iZumi Bio 51 FORMA Therapeutics 51 Ikonisys 51 Lung Cancer 51 Nasdaq MITI biopharmaceutical 51 small molecule tyrosine 51 BioAxone 51 AmpliMed 51 Reata Pharmaceuticals 51 Medical Oncology ESMO 51 Antisense Therapeutics 51 Therapeutic Vaccine 51 Medical Research Katholic 51 Xenon Pharmaceuticals 51 Endocrine Society Annual Meeting 51 Related Viruses 51 Galenea 51 Biomarker Discovery 51 protein kinase inhibitors 51 E CENP E 51 CRMD pharmaceutical 51 TorreyPines Therapeutics 51 investigational therapies 51 NYSE Amex PBTH 51 CCX# 51 Velcura Therapeutics 51 Adherex 51 Nasdaq ONXX 51 Innate Immunity 51 Onalta 51 CCR9 antagonist 51 HDAC Inhibitor 51 antibody therapeutics 51 Bladder Cancer 51 Biosimilars 51 Initiates Enrollment 51 telomerase therapeutic 51 Vaccine Adjuvant 51 Carigent 51 Marillion Pharmaceuticals 51 Diatos 51 PRNewswire FirstCall Bionovo 51 Samaritan Pharmaceuticals 51 Paratek Pharmaceuticals Inc. 51 mda 7 51 Kulmbach Germany 51 SomaLogic 51 BiTE 51 Proteolix 51 antiviral therapeutics 51 CHDI Foundation 51 miRagen Therapeutics 51 Rheumatoid Arthritis Drug 51 J.P. Morgan Healthcare 51 Mass Spectrometry 51 Endovascular Therapy 51 Epitomics 51 Viamet Pharmaceuticals 51 PsychoGenics 51 Nasdaq ARRY 51 BiTE Antibody 51 BiTE antibody 51 Adherex Technologies 51 Santaris 51 Limerick BioPharma 51 Naurex 51 Merrion Pharmaceuticals 51 Tobira Therapeutics 51 Antibody Engineering 51 Molecular Pathology 51 epigenetic therapies 51 SCYNEXIS 51 Sirtris Pharmaceuticals 51 DsiRNA molecules 51 gamma secretase inhibitors 50 HUYA Bioscience International 50 Guanilib 50 CEQ# 50 Molecular Diagnostic 50 BioContact Quebec 50 RenaMed 50 Drug Candidate 50 iCeutica 50 Liver Cancer 50 Cytometry 50 Tissue Regeneration 50 Novosom 50 Functional Genomics 50 Alnara Pharmaceuticals 50 Cellerant Therapeutics 50 OTCBB CTIX 50 antisense drugs 50 Life Sciences 50 siRNA therapeutics 50 AmpliMed Corporation 50 Monoclonal antibody 50 Scancell 50 nicotinic acetylcholine receptor 50 EyeGate Pharma 50 Nastech Pharmaceutical Company 50 Autoimmune Diseases 50 Retrovirus 50 Peptide Symposium 50 Chronic Lymphocytic Leukemia 50 Gentronix 50 Sunesis Pharmaceuticals 50 Tumor Microenvironment 50 ASCO GU 50 OGeS 50 Adenosine Therapeutics 50 Algeta ASA OSE ALGETA 50 Arriva Pharmaceuticals 50 VIA Pharmaceuticals 50 Aegerion Pharmaceuticals 50 Ceflatonin R 50 vascular disrupting agents 50 Celator 50 Principle Investigator 50 ISPOR 50 SMT C# 50 Immunex Corporation 50 Verastem 50 Alnylam Pharma 50 OTCBB PYTO 50 ProLindac 50 Thoracic Oncology 50 AIM SLN 50 Curaxin 50 Novelos Therapeutics Inc. 50 PrevOnco 50 biopharmaceutical 50 Cerenis Therapeutics 50 Silence Therapeutics plc 50 PolyTherics 50 ES Cell 50 Etubics 50 Neurotherapeutics 50 VIRxSYS 50 Xcellerex 50 Therapies 50 NSTI Nanotech 50 selective inhibition 50 Functional Genetics 50 Talabostat 50 ECTRIMS 50 Stemedica 50 Aeolus Pharmaceuticals 50 Hematology Meeting 50 Autoimmune Disease 50 molecular imaging radiopharmaceutical 50 Experimental Hematology 50 MLN# 50 Liposomal 50 histone deacetylase inhibitor 50 HDL Mimetic Peptide 50 Novel Therapies 50 MT#/MEDI-# 50 Lycera 50 Antibody 50 Symphogen 50 HSP# inhibitor 50 Traversa Therapeutics 50 anticancer therapies 50 Antibody Drug Conjugate 50 Initiates Clinical 50 NanoViricides 50 Oncology ASTRO 50 ThinkEquity Partners Growth 50 Small Molecules 50 TargeGen 50 HUPO 50 allosteric modulation 50 siRNA Delivery 50 Proteon Therapeutics 50 ENMD # 50 Pharmacogenomics 50 Anti Infectives 50 ECCMID 50 Annual ICAAC 50 humanized anti 50 immatics 50 BCR ABL inhibitors 50 theranostics 50 Bremelanotide 50 Gene Therapy 50 GAP #B# 50 Perifosine 50 RAS MAPK pathway 50 DNA methylation biomarkers 50 AEG# 50 atacicept 50 Amex KAL 50 Metabolic Profiling 50 biotherapeutics 50 OLGX 50 Abiraterone 50 ERYtech 50 entitled Synergistic 50 antisense inhibitors 50 JAK2 inhibitor 50 Prostate Cancer Symposium 50 IDM Pharma 50 ASM Biodefense 50 YONDELIS R 50 ALS MND 50 Genvec 50 Nasdaq MBRX announced 50 ERYtech Pharma 50 Abraxis Biosciences 50 Keystone Symposia 50 PI3K/mTOR 50 KaloBios Pharmaceuticals Inc. 50 Bayhill Therapeutics 50 AbD Serotec 50 therapeutic monoclonal antibody 50 ganetespib 50 Syndax 50 Alnylam Pharmaceuticals 50 Frankfurt XMP 50 Alseres Pharmaceuticals Inc. 50 NasdaqCM PSTI DAX PJT 50 Anti Angiogenesis 50 REGiMMUNE 50 NASDAQ IDEV 50 Bioenvision Nasdaq BIVN 50 ExonHit 50 Beerse Belgium 50 Pharmion Corporation 50 Gene Silencing 50 small molecule agonists 50 LEAD Therapeutics 50 Cempra 50 Tumour Vascular Disrupting Agent 50 ImmuneRegen BioSciences Inc. 50 Bionanotechnology 50 Cell Signaling 50 Announces Poster Presentations 50 specific lectin receptors 50 OTCBB IMUC 50 Chicago Multidisciplinary Symposium 50 OMP #M# 50 Trophos 50 Mersana 50 Mersana Therapeutics 50 MAbs 50 Society CTOS 50 Nanobiotix 50 selective androgen receptor modulators 50 ALN TTR 50 ASCO Breast Cancer 50 Generex Biotechnology 50 BioSciences 50 Conatus Pharmaceuticals 50 NASDAQ IDRA 50 Tibotec BVBA 50 Atugen 50 novel immunomodulatory 50 Athersys 50 Novartis Institutes 50 Pharmaceutical Scientists AAPS 50 Arrow Therapeutics 50 Protein Kinase 50 OTCBB NRGX 50 monoclonal antibody therapeutics 50 MT# MEDI 50 UEGW 50 FASgen 50 nd Annual Meeting 50 QuantaLife 50 CHDI 50 Innovative Therapies 50 Creabilis Therapeutics 50 CombinatoRx 50 Azixa 50 ImQuest 50 miRagen 50 Novel Approaches 50 Symposium SABCS 50 Pharmacogenetics 50 anionic backbone 50 Cellular Therapy ISCT 50 Dr. Aiping Young 50 Omeros Corporation 50 Atrix Laboratories 50 Nucleic Acids 50 DNA Sequencing 50 MicroRNA 50 Nasdaq DVAX 50 Archemix 50 enhance ApoA 50 CTRC AACR San Antonio 50 Biomarker Study 49 Enanta 49 TRAIL receptor 49 Personalised Medicine 49 ThermoDox R 49 Myelodysplastic Syndromes 49 Alemtuzumab 49 bluebird bio 49 JAK2 Inhibitor 49 Gefitinib 49 Gastrointestinal Cancers 49 LentiVector technology 49 Predix Pharmaceuticals 49 BioWa 49 Companion Diagnostics 49 Fidelity Biosciences 49 Amorfix 49 GTCbio 49 Neuroendocrinology 49 Calistoga Pharmaceuticals 49 Spirogen 49 novel orally administered 49 dermatology therapies 49 Echelon Biosciences 49 Completes Patient Enrollment 49 Biophysical Society 49 BiTE R 49 MEK inhibitor 49 NASDAQ SNTA biopharmaceutical 49 QuatRx 49 purinergic receptors P#X# 49 TLR antagonists 49 Factor VIIa 49 delta isoform 49 Exelixis compounds 49 Cerimon 49 Neoprobe subsidiary Cira 49 INT# [002] 49 Human Embryonic Stem 49 Hematological Malignancies 49 Connective Tissue Oncology 49 humanized monoclonal antibodies 49 Hyperion Therapeutics 49 BioFinance 49 Anticancer Drugs 49 GRN# 49 TRACON Pharmaceuticals 49 Canaccord Genuity Growth 49 Quark Biotech Inc. 49 Therapeutic Vaccines 49 Pathogenesis 49 Bioprocessing 49 Protalex Inc. 49 Genocea Biosciences 49 Neurobiological Technologies Inc. 49 VentiRx Pharmaceuticals 49 Biocept 49 Oxxon 49 NanoBioTechnology 49 therapeutic antibody 49 Therapeutic Competitors companiesandmarkets.com adEgemonye 49 Hepregen 49 proteasome inhibitors 49 RNAi therapeutics 49 ZFP Therapeutic 49 Zafgen 49 Immunotherapies 49 Hsp# inhibition 49 Profectus BioSciences 49 Next Generation Sequencing 49 ABRF 49 OPKO Health 49 Metabolic Disorders 49 Anaphore 49 Medistem 49 OPKO 49 Logical Therapeutics 49 Intarcia 49 Chemokine Therapeutics 49 Vical Incorporated 49 Protein Expression 49 Translational Medicine 49 CardioVascular BioTherapeutics Inc. 49 Initiates Phase II 49 Angiochem 49 Hematology 49 Phase 2b Clinical Trial 49 Biomolecular Sciences 49 non nucleoside inhibitor 49 NASDAQ ABII 49 angiogenesis inhibitor 49 antisense drug 49 Clinical Pharmacology 49 Repligen Corporation 49 CR# vcMMAE 49 Biologics Manufacturing 49 NYSE Amex RGN 49 OTCBB HXBM developer 49 HDAC inhibitor 49 Microbia 49 NASDAQ DYAX 49 Evotec AG 49 Kolltan Pharmaceuticals 49 investigational monoclonal antibody 49 Inflammatory Arthritis 49 Indevus Pharmaceuticals 49 NASDAQ ALNY 49 Inc. NASDAQ AVNR 49 Juvaris 49 Entest BioMedical 49 Protein Interactions 49 Biotechnology VIB 49 Berlex Biosciences 49 Blinatumomab 49 Adult Stem Cell Therapy 49 Endovasc 49 NOVAVAX 49 b3c newswire 49 Recombinant Protein 49 Anti Angiogenic 49 Nucleic Acid 49 PhotoThera 49 Oxxon Therapeutics 49 Thomas Ichim 49 OTCQX RHHBY 49 Stem Cells 49 YONDELIS 49 Inc. Nasdaq RNAI 49 immunotherapeutic 49 Genospectra 49 Transcatheter Cardiovascular Therapeutics TCT 49 KuDOS 49 Immunology 49 Serenex 49 Inovio Pharmaceuticals 49 Patent Covering 49 Urigen Pharmaceuticals Inc. 49 potently inhibit 49 novel RNAi therapeutics 49 Potentia Pharmaceuticals 49 Proteostasis 49 Inhibitors 49 Supernus Pharmaceuticals Inc. 49 Clavis Pharma 49 Neuroptix 49 Promedior 49 Mpex Pharmaceuticals 49 Halozyme Therapeutics 49 Initiates Clinical Trial 49 iPierian 49 Pharmacology 49 QuatRx Pharmaceuticals 49 PF # [002] 49 Initiates Phase III 49 Nephrology Renal Week 49 Azedra 49 Morphotek 49 J. Mazzo Ph.D. 49 Intradigm Corporation 49 Sigma Tau SpA 49 Symadex 49 Bioenvision 49 SIX RO ROG 49 Nasdaq SGMO announced 49 Cellgate Inc. 49 Alvine Pharmaceuticals 49 olaparib 49 Sigma Tau Pharmaceuticals 49 Hematology ASH Annual Meeting 49 BioScale 49 Onconova Therapeutics Inc. 49 Vitae Pharmaceuticals 49 Epidermal Growth Factor Receptor 49 elbion 49 Urology EAU 49 anti CD# antibodies 49 RenaMed Biologics 49 BrainCells 49 SGX Pharmaceuticals 49 Zelos Therapeutics 49 Welichem 49 Biophotonics 49 PharmaNova 49 Tibotec Pharmaceuticals Ltd. 49 NTDDS 49 Traficet EN 49 ProLindac TM 49 SuperAntibody 49 RNAi Therapeutic 49 Harbor BioSciences 49 molecular biomarkers 49 Affimed 49 NASDAQ OMER 49 Trodusquemine MSI 49 Neurobiological Technologies 49 mtm laboratories 49 Chemoprevention 49 Chronogen 49 InNexus 49 Canaccord Adams Hepatitis C 49 OncoTherapy Science 49 Vantia Therapeutics 49 Influenza Vaccines 49 Mytogen 49 Receptors GPCRs 49 Enzo Therapeutics 49 MedChem 49 ImmunoGen 49 Clinical Genetics 49 Allosteric 49 Atiprimod 49 Genitourinary Cancers Symposium 49 Vaccinology 49 Therapeutic Antibodies 49 ProMetic BioSciences 49 Hedgehog antagonist 49 AVEO Pharmaceuticals Inc. 49 Phase IIb Clinical Trial 49 immune modulation 49 Prima BioMed 49 OncoGenex Technologies 49 Vion Pharmaceuticals 49 Amplimmune 49 Drug Formulation 49 Alzheimer Disease ICAD 49 Molecular Insight 49 inhibit KSP 49 NASDAQ AVII developer 49 Immuno 49 Preclinical Efficacy 49 Transave 49 VistaGen Therapeutics 49 Files IND 49 Syntonix Pharmaceuticals 49 antisense 49 anticancer agents 49 Nexavar ® 49 Allon Therapeutics 49 Phenoxodiol 49 HDAC inhibitors 49 proteasome inhibitor 49 BioVex 49 Panzem R NCD 49 ImmunoVaccine Technologies 49 Adnectin 49 RXi Pharmaceuticals 49 taxane derivative 49 DMD DMSc 49 Accera 49 Nasdaq ACHN 49 GENova 49 EGFR HER 49 Islet Transplantation 49 Neurimmune 49 MaxCyte 49 OncoGenex Pharmaceuticals Inc. 49 Inflammatory Bowel Disease 49 Refractory Angina 49 CRLX# 49 Diabetes EASD 49 Inc Therapeutic Competitors 49 bevacizumab Avastin ® 49 Bavarian Nordic patented 49 Cloretazine ® 49 Aerie Pharmaceuticals 49 therapeutic monoclonal antibodies 49 Bioheart Inc.